{
    "title": "AstraZeneca's olaparib may also work in prostate cancer -expert",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2820659/AstraZenecas-olaparib-work-prostate-cancer-expert.html",
    "date": "2014-11-04",
    "keywords": [
        "cancer",
        "olaparib",
        "prostate",
        "drug",
        "repair",
        "london",
        "institute",
        "research",
        "breast",
        "astrazeneca",
        "parp",
        "market",
        "expert",
        "gmt",
        "november",
        "email",
        "light",
        "month",
        "oncologistjohann",
        "professor",
        "conference",
        "cancerolaparib",
        "enzyme",
        "cell",
        "gene",
        "cancerwhile",
        "year",
        "company",
        "promise",
        "cancerhowever",
        "test",
        "theory",
        "midstage",
        "phase",
        "trial",
        "part",
        "brca",
        "lease",
        "life",
        "dna",
        "saidit",
        "track",
        "poly",
        "polymerase",
        "inhibitor",
        "recommendation",
        "brand",
        "name",
        "medicine",
        "core",
        "focus",
        "future",
        "takeover",
        "bid",
        "pfizer",
        "drugmaker",
        "tuesday",
        "oncology",
        "business",
        "reach",
        "fastgrowing",
        "field",
        "immunotherapy",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}